Latest Period
Q4 2025
Security Snapshot
KYNTRA BIO, INC. - Common Stock, $0.01 par value (KYNB) Institutional Ownership
CUSIP: 31572Q881
13F Institutional Holders and Ownership History from Q2 2025 to Q1 2026
Institutions Reporting
31
Shares (Excl. Options)
1,150,869
Price
$8.78
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, $0.01 par value
- Symbol
- KYNB on Nasdaq
- Shares outstanding
- 4,044,489
- Price per share
- $6.78
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 1,150,869
- Total reported value
- $10,102,517
- % of total 13F portfolios
- 0%
- Share change
- +18,551
- Value change
- -$49,623
- Number of holders
- 31
- Price from insider filings
- $6.78
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- KYNB - KYNTRA BIO, INC. - Common Stock, $0.01 par value is tracked under CUSIP 31572Q881.
- 31 institutions reported positions in Q4 2025.
- 2 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 31 to 1 between Q4 2025 and Q1 2026.
- Reported value moved from $10,102,517 to $1,031.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 31 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 31572Q881?
CUSIP 31572Q881 identifies KYNB - KYNTRA BIO, INC. - Common Stock, $0.01 par value in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 31572Q881:
Significant Owners of KYNTRA BIO, INC. - Common Stock, $0.01 par value (KYNB) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 9.9% | +6% | $3,508,000 | +$192,940 | 400,000 | +5.8% | Armistice Capital, LLC | 31 Dec 2025 |
| VANGUARD GROUP INC | 4.4% | $916,888 | 178,040 | The Vanguard Group | 30 Jun 2025 |
As of 31 Dec 2025, 31 institutional investors reported holding 1,150,869 shares of KYNTRA BIO, INC. - Common Stock, $0.01 par value (KYNB). This represents 28% of the company’s total 4,044,489 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of KYNTRA BIO, INC. - Common Stock, $0.01 par value (KYNB) together control 28% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 9.9% | 400,000 | +5.8% | 0.09% | $3,512,000 |
| VANGUARD GROUP INC | 4.5% | 181,973 | -1.2% | 0% | $1,597,723 |
| ACADIAN ASSET MANAGEMENT LLC | 2.6% | 105,585 | -4.3% | 0% | $925,000 |
| BlackRock, Inc. | 2.1% | 84,690 | -0.07% | 0% | $743,579 |
| TWO SIGMA INVESTMENTS, LP | 1.5% | 61,211 | +52% | 0% | $537,433 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1% | 43,704 | +0.05% | 0% | $383,805 |
| HighTower Advisors, LLC | 0.98% | 39,746 | 0% | 0% | $348,970 |
| MARSHALL WACE, LLP | 0.8% | 32,502 | -55% | 0% | $285,366 |
| RENAISSANCE TECHNOLOGIES LLC | 0.78% | 31,681 | +8.2% | 0% | $278,159 |
| DRW Securities, LLC | 0.75% | 30,420 | +171% | 0.02% | $267,087 |
| TWO SIGMA ADVISERS, LP | 0.56% | 22,809 | 0% | $200,263 | |
| STATE STREET CORP | 0.5% | 20,284 | 0% | 0% | $178,094 |
| CITADEL ADVISORS LLC | 0.41% | 16,756 | -29% | 0% | $147,117 |
| NORTHERN TRUST CORP | 0.32% | 12,852 | 0% | $112,841 | |
| JANE STREET GROUP, LLC | 0.31% | 12,497 | 0% | $109,723 | |
| Squarepoint Ops LLC | 0.3% | 12,186 | -26% | 0% | $106,993 |
| ADAR1 Capital Management, LLC | 0.26% | 10,469 | 0.01% | $91,918 | |
| Corient Private Wealth LLC | 0.25% | 10,013 | 0% | $87,914 | |
| UBS Group AG | 0.23% | 9,432 | +8.8% | 0% | $82,813 |
| MORGAN STANLEY | 0.15% | 5,924 | +283% | 0% | $52,012 |
| GROUP ONE TRADING LLC | 0.11% | 4,588 | -0.86% | 0% | $40,283 |
| BANK OF AMERICA CORP /DE/ | 0.01% | 595 | 0% | 0% | $5,225 |
| CIBC Private Wealth Group LLC | 0.01% | 287 | 0% | 0% | $2,520 |
| Tower Research Capital LLC (TRC) | 0.01% | 216 | -25% | 0% | $1,896 |
| SBI Securities Co., Ltd. | 0% | 152 | 0% | 0% | $1,335 |